Charles C.-Y. Shih - Concepedia

Author

Charles C.-Y. Shih

Also Known As

C C Shih, C. Shih, CHARLES C-Y SHIH, CHARLES C-Y. SHIH, Charles C-Y Shih, Charles C-Y. Shih, Charles C. -Y. Shih, Charles C.-Y Shih, Charles C.-Y. Shih, Charles Shih

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

AndroScience (United States)University of North Carolina at Chapel Hill Medical College of Wisconsin Children's Hospital of Wisconsin Children's Cancer Center

About

Charles C.-Y. Shih is an author at AndroScience (United States) specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	579
2	Natural Sciences	4	4	255
3	Biochemistry	3	3	128
4	Social Sciences	2	2	143
5	Engineering	1	1	11

Charles C.-Y. Shih

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Antitumor Agents. 217. Curcumin Analogues as Novel Androgen Receptor Antagonists with Potential as Anti-Prostate Cancer Agents Hironori Ohtsu, Zhiyan Xiao, Junko Ishida, Journal of Medicinal Chemistry	2002	267
Antitumor Agents. 250. Design and Synthesis of New Curcumin Analogues as Potential Anti-Prostate Cancer Agents Lin Li, Qian Shi, Alexander K. Nyarko, Journal of Medicinal Chemistry	2006	173
Differential expression of peroxiredoxin subtypes in human brain cell types Theodore A. Sarafian, M. Anthony Verity, Harry V. Vinters, Journal of Neuroscience Research Prx GenesPeroxiredoxin SubtypesAntioxidant EnzymesRedox BiologyCellular Physiology	1999	131
Localization, interaction, and RNA binding properties of the V(D)J recombination-activating proteins RAG1 and RAG2 Eugenia Spanopoulou, Patricia Cortés, Charles C.-Y. Shih, Immunity Natural SciencesImmunologyRna BiologyMolecular BiologySmall Rna	1995	99
Role of Platelet-Endothelial Cell Adhesion Molecule (PECAM) in Platelet Adhesion/Aggregation Over Injured but Not Denuded Endothelium In Vivo and Ex Vivo William I. Rosenblum, G H Nelson, Brandon Wormley, Stroke	1996	75
Antitumor agents 247. New 4-ethoxycarbonylethyl curcumin analogs as potential antiandrogenic agents Lin Li, Qian Shi, Ching‐Yuan Su, Bioorganic & Medicinal Chemistry Medicinal ChemistryAntitumor Agents 247MedicinePolymer-drug ConjugatePharmacotherapy	2006	75
A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy Laura C. Bott, Nisha M. Badders, Ke‐lian Chen, Human Molecular Genetics Drosophila Nrf1Molecular BiologyNrf2 Activator MitigatesOxidative StressSmall-molecule Nrf1	2016	74
Studies on the arrangement of glucocorticoid receptors in the plasma membrane of S-49 lymphoma cells Bahiru Gametchu, Cheryl S. Watson, Charles C.-Y. Shih, Steroids Signal TransductionPlasma MembraneGlucocorticoid ReceptorsImmunologyReceptor (Biochemistry)	1991	47
MANIPULATION OF GRAFT-VERSUS-HOST DISEASE FOR A GRAFT-VERSUS-LEUKEMIA EFFECT AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION IN AKR MICE WITH SPONTANEOUS LEUKEMIA/LYMPHOMA1 Robert L. Truitt, Charles C.-Y. Shih, Ann V. LeFever Transplantation	1986	45
Antitumor agents 222. † †For Part 221, see ref 1. Synthesis and anti-androgen activity of new diarylheptanoids Hironori Ohtsu, Hideji Itokawa, Zhiyan Xiao, Bioorganic & Medicinal Chemistry Anti-androgen ActivityMolecular PharmacologyMedicinal ChemistryAntitumor Agents 222Biochemistry	2003	43

Page 1